Anticancer natural products from the Middle East and North Africa: biodiversity, mechanisms, and translational challenges - Takeaways - MDSpire

Anticancer natural products from the Middle East and North Africa: biodiversity, mechanisms, and translational challenges

  • By

  • Razane Hamiyeh

  • Zahraa Salhab

  • Hisham F. Bahmad

  • Antoine G. Abou Fayad

  • Wassim Abou-Kheir

  • July 6, 2026

  • 0 min

Share

  • 1

    Cancer is a leading cause of morbidity and mortality globally, with significant clinical and economic burdens.

  • 2

    Natural products from the MENA region show promise as anticancer agents with diverse mechanisms of action.

  • 3

    Technological innovations are enhancing the discovery of natural anticancer compounds through advanced screening and biosynthetic methods.

  • 4

    The MENA region is an underexplored source of biodiverse natural products with potential therapeutic applications in cancer.

  • 5

    Addressing disparities in cancer incidence and treatment access is crucial, particularly in low- and middle-income countries.

Original Source(s)

Anticancer natural products from the Middle East and North Africa: biodiversity, mechanisms, and translational challenges

  • by Razane Hamiyeh, Zahraa Salhab, Hisham F. Bahmad, Antoine G. Abou Fayad, Wassim Abou-Kheir

  • July 6, 2026

Related Content

Cytokine delivery and targeting strategies in pet dogs with cancer: a comparative immuno-oncology approach

A cost-effective 3D-printed cement spacer reconstruction in a rare case of calcaneal Ewing sarcoma: a case report and surgical technique

Prostate Cancer Screening—Where We’ve Been, Where We Are, and What Comes Next